Dan Veljovich, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GSK
    Topic:
    Parp inhibitor consulting and speaker's bureau
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Topic:
    Parp inhibitor consulting and speaker's bureau
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eisai
    Topic:
    Immunotherapy and TKI for uterine cancer
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Topic:
    Immunotherapy and TKI for uterine cancer
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    ADPT Adaptive BIotech
    Topic:
    Stockholder
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    ABBV Abbvie
    Topic:
    Stockholder
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    AZN AstraZeneca
    Topic:
    Stockholder
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    CVS CVS Health
    Topic:
    Stockholder
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    DOCS DOximity
    Topic:
    Stockholder
    Date added:
    08/24/2022
    Date updated:
    04/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    GILD GIlead
    Topic:
    Stockholder
    Date added:
    08/24/2022
    Date updated:
    04/25/2024

Pages

Return to Alaska Hematology Oncology Conference